HALOPERIDOL

Important: Therapy notes

MHRA advice: Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium (December 2021) (www.gov.uk).

Important: Formulation and dosage details

Formulation:

Tablets 1·5mg, 5mg, 10mg

Dosage:

500 micrograms to 1·5mg 3 times daily adjusted according to response. 10mg daily may occasionally be required in Tourette syndrome.

Important: Formulation and dosage details

Formulation:

Oral liquid 10mg/5mL

Dosage:

500 micrograms to 1·5mg 3 times daily adjusted according to response. 10mg daily may occasionally be required in Tourette syndrome.

Important: Formulation and dosage details

Formulation:

Solution for injection 5mg/mL

TETRABENAZINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 25mg

Dosage:

Movement disorders, initially 12·5mg twice daily (older patients 12·5mg daily) gradually increased to 12·5mg to 25mg 3 times daily; maximum 200mg daily.  Moderate to severe tardive dyskinesia, initially 12·5mg daily; gradually increased according to response.

TRIHEXYPHENIDYL

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 2mg, 5mg (s)

Notes:

Anticholinergic.

CLONIDINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 25 micrograms (s)

Dosage:

Used for Tourette syndrome off-label.

Editorial Information

Document Id: F096